A Clinical Trial of XZP-6019 Tablets in Healthy Subjects

Clinical trial NCT05063968 · UNKNOWN

Trial details

NCT number: NCT05063968
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease

Start date: 2021-11-30
Primary completion: 2022-09-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.